Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Organisation › Details

Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.)

The CI3 excellence cluster pools the outstanding expertise in the Rhine-Main cluster region of Germany involving innovative new therapies and diagnostics in the field of individualised immune intervention. To this end, CI3 is putting together a network of players from the business, research and healthcare communities as well as government and is shaping the integral element across the entire innovation and value creation chain. *

 

Period Start 2011-04-14 existent
Product Industry pharmacogenomics/pharmacogenetics
Persons Person Türeci, Özlem (Ganymed 200811 CEO + CSO)
  Person 2 Wessel, Rainer (CI3 201210 Cluster Manager before Ganymed CEO)
     
Region Region Mainz
  Country Germany
  Street 17–19 Kupferbergterrasse
  City 55116 Mainz
  Tel +49-6131-6230581
    Address record changed: 2018-07-24
     
Basic data Employees n. a.
     
    * Document for �About Section�: Zedira GmbH. (6/25/12). "Press Release: Zedira, Dr. Falk Phama and the University of Mainz Hospital, which Together Comprise a Flagship Project of the CI3 Excellence Cluster, Are to Receive Subsidy Funding for Clinical Development of a Celiac Disease Dru
     
   
Record changed: 2018-04-29

Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 600x80px

More documents for Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2018 Boston Partnering 560x80px




» top